Elsbernd Brian — SEC Form 4 filings
SEC reporting owner CIK 1763511. 15 Form 4 filings on record with FilingPulse; latest filed 2026-07-17.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-02-16 to 2026-07-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 6 filings — 221,231 shares, $4,648,836 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 50.
- Largest priced transaction: sale of 53,255 shares @ $22.93 ($1,221,137) in CATALYST PHARMACEUTICALS, INC., filed 2025-03-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Legal Officer | 15 | — | 9 legs · 221,231 sh · $4,648,836 | 50 |
Form 4 filings — Elsbernd Brian
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-17 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Disposition to issuer (D): 242,501 @ $31.50 · Disposition to issuer (D): 132,000 (derivative) @ $0 · Disposition to issuer (D): 200,000 (derivative) @ $0 · Disposition to issuer (D): 135,000 (derivative) @ $0 · Disposition to issuer (D): 69,000 (derivative) @ $0 · Disposition to issuer (D): 147,621 (derivative) @ $0 · +5 more | EDGAR |
| 2025-12-30 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 6,667 · Tax withholding (F): 2,623 · Option exercise (M): 6,667 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 7,067 · Tax withholding (F): 2,780 · Option exercise (M): 7,067 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 5,161 · Tax withholding (F): 2,030 · Grant/award (A): 98,652 (derivative) @ $0 · Grant/award (A): 29,776 (derivative) @ $0 · Option exercise (M): 5,161 (derivative) @ $0 | EDGAR |
| 2025-11-14 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Sale (S): 40,000 @ $22.70 | EDGAR |
| 2025-09-10 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 112,475 @ $2.24 · Sale (S): 30,000 @ $20.30 · Option exercise (M): 112,475 (derivative) @ $0 | EDGAR |
| 2025-09-05 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 20,000 @ $2.24 · Sale (S): 20,000 @ $20.08 · Option exercise (M): 30,000 @ $2.24 · Sale (S): 30,000 @ $19.52 · Option exercise (M): 20,000 (derivative) @ $0 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 9,270 @ $2.24 · Sale (S): 9,720 @ $23.23 · Option exercise (M): 53,255 @ $2.24 · Sale (S): 53,255 @ $22.93 · Option exercise (M): 9,270 (derivative) @ $0 · Option exercise (M): 53,255 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 9,667 · Tax withholding (F): 2,353 · Option exercise (M): 9,667 (derivative) @ $0 | EDGAR |
| 2024-12-31 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 6,667 · Tax withholding (F): 1,941 · Option exercise (M): 6,667 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 7,067 · Tax withholding (F): 1,720 · Option exercise (M): 7,067 (derivative) @ $0 | EDGAR |
| 2024-11-29 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 50,244 @ $4.01 · Sale (S): 9,300 @ $21.65 · Option exercise (M): 9,756 @ $4.01 · Sale (S): 3,956 @ $21.58 · Option exercise (M): 50,244 (derivative) @ $0 · Option exercise (M): 9,756 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Grant/award (A): 126,704 (derivative) @ $0 · Grant/award (A): 15,483 (derivative) @ $0 | EDGAR |
| 2024-03-28 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Sale (S): 25,000 @ $16.44 | EDGAR |
| 2024-02-16 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 9,667 · Tax withholding (F): 2,353 · Option exercise (M): 9,667 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1763511 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →